Natalizumab treatment reduces endothelial activity in MS patients
To access this article, please choose from the options below
PII: S0165-5728(10)00303-6
doi:10.1016/j.jneuroim.2010.07.012
© 2010 Elsevier B.V. All rights reserved.
PII: S0165-5728(10)00303-6
doi:10.1016/j.jneuroim.2010.07.012
© 2010 Elsevier B.V. All rights reserved.